InvestorsHub Logo
Followers 2
Posts 189
Boards Moderated 0
Alias Born 04/28/2017

Re: None

Thursday, 09/21/2017 1:44:50 AM

Thursday, September 21, 2017 1:44:50 AM

Post# of 199
Amazing valuation opportunity. NASH 3 trials, 2 fully funded by US NIH. NASH Ph2b results b4 Dec 31st 2017. Q1 2018, NASH transaction, lump of cash say USD$100mio-250mio & no more dilution, no more R&D on NASH as Bigpharma pay ut & then say 15% of NAFLD/NASH sales income. Meanwhile progress CDiff which is worth billions for ongoing revenue of buyout. This board shows noone knows!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IMRN News